The etiology of primary open angle glaucoma, a leading cause of age-related blindness, remains poorly defined, although elevated intraocular pressure (IOP) contributes to disease progression. To better understand the mechanisms causing elevated IOP from aqueous humor circulation, we pursued proteomic analyses of trabecular meshwork (TM) from glaucoma and age-matched control donors. These analyses demonstrated cochlin, a protein associated with deafness disorder DFNA9, to be present in glaucomatous but absent in normal TM. Cochlin was also detected in TM from the glaucomatous DBA/2J mouse preceding elevated IOP but found to be absent in three other mouse lines that do not develop elevated IOP. Histochemical analyses revealed co-deposits of cochlin and mucopolysaccharide in human TM around Schlemm's canal, similar to that observed in the cochlea in DFNA9 deafness. Purified cochlin was found to aggregate after sheer stress and to induce aggregation of TM cells in vitro. Age dependent in vivo increases in cochlin were observed in glaucomatous TM, concomitant with a decrease in type II collagen, suggesting that cochlin may disrupt the TM architecture and render components like collagen more susceptible to degradation and collapse. Overall, these observations suggest that cochlin contributes to elevated IOP in primary open angle glaucoma through altered interactions within the TM extracellular matrix, resulting in cell aggregation, mucopolysaccharide deposition, and significant obstruction of the aqueous humor circulation.
INTRODUCTION
Glaucoma encompasses a group of blinding diseases generally classified as primary, with no known etiology, or as secondary, where a previous illness or injury is contributory. Primary open angle glaucoma (POAG)* is the most common form of the disease, affecting 3 million Americans and over 70 million people worldwide (1) . Vision loss in most but not all glaucoma is related to increased intraocular pressure (IOP) with subsequent damage to the optic nerve. The molecular basis of the pathology is poorly understood but the risk for POAG clearly increases with age, and ethnicity plays a role (eg, blacks exhibit more POAG than whites and with an earlier age of onset). While specific genes have been implicated in glaucoma pathology, including for example, TIGR and its gene product of unknown function, myocilin, genetic studies to date remain inconclusive regarding glaucoma disease mechanisms (2) .
Elevated IOP typically develops in glaucoma as a result of impeded aqueous humor outflow (3) . Aqueous humor is actively produced by the ciliary epithelium in the posterior chamber of the eye and circulates through the pupil to the anterior chamber where it drains through the trabecular meshwork (TM) into Schlemm's canal and the episcleral veins (4) . Resistance to outflow commonly occurs in the TM which has a complex extracellular matrix (ECM) comprised of collagen beams lined with endotheliallike cells (5,6). The mechanisms of resistance are not known, however the pseudoendothelial cells in the TM produce a mucopolysaccharide (MPS) (7) that appears to function in attracting macrophages for phagocytic self-cleaning of the TM (8) .
Loss of control of MPS levels in the TM appears to disrupt the self cleaning process, and can result in large changes in IOP (9) . In other sensory systems, MPS deposits in the cochlea have been associated with the late onset and progressive auditory and vestibular disorder DFNA9 that involves increased intracranial pressure (10, 11) . Drugs for treating POAG slow disease progression by reducing aqueous production or increasing aqueous outflow but do not provide a cure. Trabeculectomy is the most common last resort treatment for POAG and involves surgical removal of a small amount of TM tissue and redirection of the aqueous flow through the conjunctiva to the episcleral vessels. Toward a better understanding of the molecular mechanisms involved in glaucoma and specifically in blockage of aqueous outflow, we initiated a classical proteomics study to compare the protein composition of glaucomatous TM obtained by trabeculectomy with that of normal TM. Here we present evidence that cochlin, a protein associated with auditory disorder DFNA9, is absent in normal TM but increases with age in glaucomatous TM in association with MPS deposits.
EXPERIMENTAL PROCEDURES
Tissue Procurement. Human eyes from 35 normal donors and 5 POAG donors, all between the ages of 40 and 85 years of age, were used in this study and obtained through the Cleveland Eye Bank. Eyes were enucleated within 12h of death and stored at -80ºC until TM tissue was isolated by dissection. Normal control eyes were from donors with no visual field defects, no evidence of glaucoma and without central nervous system abnormalities. Recombinant cochlin and recombinant Notch-1 (ECN) were produced in COS-7 cells with 3-HA and 4-HA epitope tags, respectively, using the pcDNA 3.0 vector and SuperFect transfection reagent (Qiagen, Valencia, CA) (18, 19) . The proteins were affinity purified from the media of transiently transfected COS-7 cells using rabbit anti-HA antibody (Y-11; Santa Cruz Biotechnology Inc., Santa Cruz, CA) coupled to protein A agarose beads with dimethylpimelimindate. Purified recombinant cochlin was subjected to sheer stress by passing the protein (5 µg) through a Hamilton syringe (50 µl) five times in 50 mM TrisCl pH7.5, 125 mM NaCl, 0.1% genapol then analyzed by non-reducing SDS-PAGE immunoblotting.
RESULTS

Cochlin is uniquely associated with glaucomatous TM. Protein extracts from 6
POAG and 6 normal TM tissues were subjected to SDS-PAGE, gel slices excised ( Fig.   1A ) and proteins identified using well established mass spectrometric and bioinformatic methods. Overall, 368 proteins were identified, 52 of which were only detected in glaucomatous TM but with variable frequency (Supplemental Table 1 Nevertheless, our Western analysis reproducibly failed to detect the protein in nonglaucomatous tissues regardless of the amount of TM analyzed, strongly suggesting cochlin to be absent or in very low abundance in normal TM.
Cochlin is the product of the COCH (Coagulation factor C Homology) gene and its FCH domain is mutated in patients with the autosomal dominant nonsyndromic auditory and vestibular disorder DFNA9 (25, 26) . COCH mutations have also been implicated in Menière disease (with features of hearing loss and vertigo)(27) and in presbyacusis (age related hearing loss) (28) . These disorders are late-onset and progressive in nature and parallel the clinical manifestations of POAG. Cochlin comprises the major non-collagen component of the ECM of the inner ear (29) but is also expressed in very low levels in the cerebellum and eye (25, 30) . Localization of cochlin within the eye has not been previously reported. The protein structure is highly conserved, with human cochlin exhibiting 94% and 79% amino acid sequence identity, respectively, with the mouse and chicken proteins. Cochlin is a secreted protein with three glycosylated isoforms detectable in human cochlea with apparent masses of ~40 KDa, 46 KDa and ~60 KDa (15, 18, 31) . Two cochlin isoforms (~46 KDa and ~60 KDa)
were detected in glaucomatous TM, however, the antibody we used recognizes only the higher molecular weight isoforms (18) . Misfolded cochlin has been implicated in the formation of cochlear deposits in DFNA9; interestingly, the ~40 and 46 KDa isoforms contain vWFA-like domains but lack the amino-terminal FCH domain which contains the disease associated mutations (18) . Cochlin has been suggested to play a structural role in the architecture of the cochlea by binding to components of the ECM (25, 30) . In patients with DFNA9, there is a marked decrease in cellularity and an accumulation of eosinophilic deposits that obstruct the cochlear and vestibular nerve channels (16, 25, 32) . In patients with POAG, cochlin expression in the TM increases with age along with acidophilic cochlin deposits around Schlemm's canal, apparently formed by interactions with MPS and other ECM components.
Cochlin vWFA-like domains may contribute significantly to deposit formation in TM as hydrodynamic forces induce vWF aggregation in suspension and may influence cell adhesion rates in the circulation (33 Coomassie stained SDS-PAGE of purified recombinant cochlin and Notch. E. Western analysis of purified recombinant cochlin (~2 µg) and recombinant Notch (~1 µg) using polyclonal rabbit anti HA-antibody. F. Western analysis after non-reducing 10% SDS-PAGE of purified recombinant cochlin using anti-cochlin antibody before (-) and after (+)
sheer stress revealing stress-induced higher mass aggregates. Non-glaucomatous Glaucomatous 
